Abbott Diagnostics Educational Program
Cardiac || Hematology || Instrument Systems
Instrument Systems
ARCHITECT® c16000/ci16200: A New High-Volume Clinical Chemistry and Integrated System
Sally Gough, B.S.
Medical Technologist, Outreach Laboratory Manager
Sarasota Memorial Health Care Systems
Sarasota, Florida
Sarasota Memorial Health Care Systems
Sarasota, Florida
- A family of integrated clinical chemistry/immunoassay systems offers significant process improvement options to clinical laboratories. Individual laboratories have their own unique challenges and needs, and "a one size fits all" approach to laboratory automation is not practical to provide optimal solutions.
- Performance validation and process improvement studies of a new system (ci16200), conducted at typical clinical laboratories that served as familiarization sites, are reviewed. The new analyzer provides more options for the Architect family of clinical chemistry, immunoassay, and integrated analyzers.
- Family modules can be used individually or as integrated systems to harmonize laboratory networks by producing equivalent test results for patient specimens regardless of the analyzer used or the specific laboratory performing the analysis.
Case Study of Process Improvement With an Integrated System, ACT Laboratories, Canberra, Australia
Peter E. Hickman, M.B.B.S., Ph.D.
Director of Chemical Pathology in ACT Pathology; Associate Professor
Australia National University Medical School
Canberra, Australia
Australia National University Medical School
Canberra, Australia
- A family of integrated clinical chemistry/immunoassay systems offers significant process improvement options to clinical laboratories. Individual laboratories have their own unique challenges and needs, and "a one size fits all" approach to laboratory automation is not practical to provide optimal solutions.
- Use of an integrated system, the Architect ci8200, for test consolidation and enhanced operational efficiency in a major laboratory is also described. Advantages of the clinical chemistry and immunoassay analyzer family concept, specifically including the ability to fit low, mid, and high volume testing needs using the same reagents and matching analytical performance, is emphasized.
- Family modules can be used individually or as integrated systems to harmonize laboratory networks by producing equivalent test results for patient specimens regardless of the analyzer used or the specific laboratory performing the analysis.
Program Brochure [pdf]
Cardiac
Patient Management and Role of Troponin in ACS
Professor Dr. Eckart Fleck
Heart Center
Berlin, Germany
Berlin, Germany
- Laboratory medicine may not always receive the recognition it deserves, but it plays a critical role in today's healthcare. The life-saving work medical laboratory scientists provide, aids in the early detection of disease, improves patient management and lives, and lowers overall health-care cost.
- Improving cardiovascular care is a major focus of hospitals and healthcare facilities. Cardiac biomarkers are vital in the diagnosis and care of patients with acute coronary syndrome (ACS), ischemia and heart failure. The workshop will provide a clinical perspective on the integral role of biomarkers in the treatment of acute coronary syndrome.
Program Brochure [pdf]
Integration and Impact on Turnaround Time and Cost
Professor Peter George
Clinical Director
Canterbury Health Laboratories
Christchurch, New Zealand
Canterbury Health Laboratories
Christchurch, New Zealand
- Laboratory medicine may not always receive the recognition it deserves, but it plays a critical role in today’s healthcare. The life-saving work medical laboratory scientists provide, aids in the early detection of disease, improves patient management and lives, and lowers overall health-care cost.
- The impact of improved laboratory efficiency on patient care and the emergency department demonstrates decreased TAT in the lab, its association with decreased TAT in the ER, and ultimately a more rapid treatment of patients in the ED.
Program Brochure [pdf]
MPO and Risk Assessment
Stanley L. Hazen, M.D., Ph.D.
Section Head, Preventive Cardiology and Rehabilitation;
Professor of Molecular Medicine, Cell Biology and Cardiovascular Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland, Ohio
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland, Ohio
- Laboratory medicine may not always receive the recognition it deserves, but it plays a critical role in today’s healthcare. The life-saving work medical laboratory scientists provide, aids in the early detection of disease, improves patient management and lives, and lowers overall health-care cost.
- Risk Assessment using MPO for the early prediction of vulnerable plaque and risk for cardiac events will be discussed.
Program Brochure [pdf]
Biomarker Study (ARROW)
Alan H. B. Wu, Ph.D., D.A.B.C.C.
Chief, Clinical Chemistry and Toxicology, San Francisco General Hospital; Professor of Laboratory Medicine, University of California
San Francisco, California
San Francisco, California
- Laboratory medicine may not always receive the recognition it deserves, but it plays a critical role in today’s healthcare. The life-saving work medical laboratory scientists provide, aids in the early detection of disease, improves patient management and lives, and lowers overall health-care cost.
- The workshop discussed a new prospective study that puts 13 promising biomarkers to the test.
Program Brochure [pdf]
Hematology
Neutrophil CD64 Expression Is a Marker of Sepsis or Infection
Henry M. Rinder, M.D.
Associate Professor of Laboratory Medicine and Internal Medicine; Director, Clinical Hematology Laboratory
Yale University School of Medicine
New Haven, Connecticut
Yale University School of Medicine
New Haven, Connecticut
- Rapid diagnosis of serious community-acquired infections is essential to improve prognosis. Neutrophil CD64 expression has been proposed as an improved laboratory indicator of severe infection and sepsis.
- This preliminary study of neutrophil CD64 expression in outpatients suggests that it is an improved laboratory parameter in identifying patients with serious infections and those at risk for bacteremia defined by clinical criteria. Sequential analysis of neutrophil CD64 may further improve the diagnostic efficiency for infection/sepsis detection. Analysis of the remaining 304 patients is underway to confirm and enlarge these findings.
Program Brochure [pdf]
Next Generation of Automated Hematology: PMN CD64 for Infection/Sepsis Detection
Bruce H. Davis, M.D.
President
Trillium Diagnostics
Brewer, Maine
Trillium Diagnostics
Brewer, Maine
- Rapid diagnosis of serious community-acquired infections is essential to improve prognosis. Neutrophil CD64 expression has been proposed as an improved laboratory indicator of severe infection and sepsis.
- This preliminary study of neutrophil CD64 expression in outpatients suggests that it is an improved laboratory parameter in identifying patients with serious infections and those at risk for bacteremia defined by clinical criteria. Sequential analysis of neutrophil CD64 may further improve the diagnostic efficiency for infection/sepsis detection. Analysis of the remaining 304 patients is underway to confirm and enlarge these findings.
Program Brochure [pdf]
Instrument Systems
ARCHITECT® i1000SR: A New Low-Mid Volume Chemiluminescent Immunoassay System
Sherry L. Perkins, Ph.D.
Head, Division of Biochemistry;
Associate Professor, Department of Pathology and Laboratory Medicine
The Ottawa Hospital
Ottawa, Canada
The Ottawa Hospital
Ottawa, Canada
- A family of integrated clinical chemistry/immunoassay systems offers significant process improvement options to clinical laboratories. Individual laboratories have their own unique challenges and needs, and "a one size fits all" approach to laboratory automation is not practical to provide optimal solutions.
- Performance validation and process improvement studies of a new system (i1000SR), conducted at typical clinical laboratories that served as familiarization sites, are reviewed. The new analyzer provides more options for the Architect family of clinical chemistry, immunoassay, and integrated analyzers.
- Family modules can be used individually or as integrated systems to harmonize laboratory networks by producing equivalent test results for patient specimens regardless of the analyzer used or the specific laboratory performing the analysis.
Program Brochure [pdf]
Email questions about PACE credits to PACE@abbott.com
